Trauma Clinical Trial
Official title:
Plasma Cytochrome c as Biomarker of Traumatic Injury and Predictor of Outcome
Cytochrome c is a mitochondrial protein that plays a key role in energy metabolism. When mitochondria are injured, cytochrome c may leave mitochondria and reach the bloodstream. The investigators plan to investigate whether circulating cytochrome c levels may serve as biomarker of traumatic injury correlating with (1) severity of traumatic injury, (2) development of organ dysfunction, and (3) clinical outcomes. The Trauma Services at ALGH will enroll over 8 months 100 consecutive trauma patients who require intubation for mechanical ventilation and survive to hospital admission. The Resuscitation Institute at RFUMS will measure cytochrome c levels in plasma taken upon hospital admission and subsequently at 24, 48, and 72 hours, with additional plasma stored for markers to be defined at a later time. Blood cytochrome c levels will be analyzed in relation to severity of traumatic injury, development of organ dysfunction, and clinical outcomes including survival and functional status (adjusted for covariates such as age, gender, type of trauma, time to stabilization, comorbidities, etc.) using information obtained as part of routine medical care. Successful completion of this project will support blood cytochrome c as biomarker of traumatic injury which could be used to identify severity, predict outcomes, and assess novel mitochondrial protective strategies.
The investigators propose to determine whether plasma cytochrome c could serve as clinical
biomarker of traumatic injury by examining the relationship between plasma levels of
cytochrome c and the severity of the initial injury upon arrival to the hospital, subsequent
development of organ dysfunction, and clinical outcomes. Cytochrome c is a mitochondrial
protein that plays a crucial role in energy metabolism enabling transfer of electrons from
complex III (i.e., cytochrome c reductase) to complex IV (cytochrome c oxidase). Upon
mitochondrial injury and contingent on severity, cytochrome c may be released to the cytosol
and subsequently to the bloodstream. The rationale for this project stems from: (1)
observations at the Resuscitation Institute in animal models of cardiac arrest and
resuscitation in which plasma cytochrome c correlates directly with the severity of
post-resuscitation left ventricular dysfunction and inversely with survival and (2)
observations by others reporting a correlation between plasma cytochrome c and severity of
organ injury. The investigators hypothesize that plasma cytochrome c measured upon arrival to
the hospital reflects the severity of the initial traumatic injury resulting from the
aggregate effects of direct injury to organs, ischemic injury consequent to blood loss,
delays in stabilization, and preexistent comorbidity - all factors that can injure
mitochondria. The investigators further hypothesize that the initial cytochrome c plasma
level combined with the levels measured during the subsequent three days of hospitalization
correlate with the development of organ dysfunction, and clinical outcomes. The current
proposal is structured in three specific aims:
Specific Aim 1 (collection of blood samples and clinical data): For this aim the investigator
plans to enroll 100 consecutive trauma victims admitted to Advocate Lutheran General Hospital
(ALGH) over a period of 8 months presenting with single or multisystem injuries and meeting
specific entry and exclusion criteria developed to ensure a broad range of injury severity.
Blood will be sampled within 15 minutes of hospital arrival (e.g., in the Emergency
Department or Operating Room) and subsequently at 24, 48, and 72 hours. Plasma will be
separated and stored at −80 °C for subsequent batch measurement of cytochrome c (and other
markers of mitochondrial injury that may become available at the time of analysis) in the
Resuscitation Institute at Rosalind Franklin Univer-sity of Medicine and Science (RFUMS).
Clinical data will be extracted from tools used clinically - including the Illinois Trauma
Registry Worksheet and the medical record - and used to: (i) record severity of initial
traumatic injury by calculating the Trauma Score - Injury Severity Score (TRISS) along with a
detailed assessment of individual organs injury; (ii) estimate the severity of blood loss
based on base deficit and transfusion needs; (iii) determine subsequent development of organ
dysfunction by calculating the Multiple Organ Dysfunction Score (MODS) and the Sequential
Organ Failure Score; and (iv) assess outcomes by measuring length of stay in the Intensive
Care Unit (ICU), length of stay in the hospital, survival upon hospital discharge, and
functional status upon hospital discharge.
Specific Aim 2 (analysis of plasma cytochrome c): Frozen samples of arterial plasma, stored
at −80°C at ALGH, will be transferred to the Resuscitation Institute at RFU and cytochrome c
measured using electrochemiluminescence.
Specific Aim 3 (statistical analysis and modeling): A database devoid of patient identifiers
will be created merging the clinical information with values of plasma cytochrome c levels
and other markers as they become available. Considering the pilot nature of the project,
statistical modeling and analysis will be primarily exploratory focused on identifying
relationships between plasma cytochrome c levels upon hospital arrival and clinical elements
contributing of the severity of primary traumatic injury. The analysis and modeling will also
include examining the predictive value of the initial and subsequent plasma cytochrome c
levels on development of organ dysfunction and clinical outcomes.
The long-term goal of the project is to develop plasma cytochrome c as biomarker of traumatic
injury and other clinical conditions associated with mitochondrial injury that could be used
at the bedside - i.e., after developing point of care assays - for (1) assessing severity of
illness, (2) prognostication of outcome, and (3) clinical re-search on novel therapeutic
interventions aimed at reducing mitochondrial injury.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04848376 -
Post-Market Clinical Follow-up Study of A-SPINE's Products
|
||
Terminated |
NCT03781817 -
Intranasal Versus Intravenous Ketamine for Procedural Sedation in Children With Non-operative Fractures
|
Phase 4 | |
Completed |
NCT04342416 -
Using a Brief Visuospatial Interference Intervention to Reduce Intrusive Memories Among Trauma Exposed Women
|
N/A | |
Recruiting |
NCT04856449 -
DBT Skills Plus EMDR for BPD and Trauma
|
N/A | |
Completed |
NCT04356963 -
Adjunct VR Pain Management in Acute Brain Injury
|
N/A | |
Completed |
NCT05669313 -
The Effects of Hypothermia and Acidosis on Coagulation During Treatment With Rivaroxaban Measured With ROTEM
|
||
Active, not recruiting |
NCT03622632 -
Pilot Study to Measure Uric Acid in Traumatized Patients: Determinants and Prognostic Association
|
||
Recruiting |
NCT04725721 -
Testing FIRST in Youth Outpatient Psychotherapy
|
N/A | |
Active, not recruiting |
NCT05530642 -
An Augmented Training Program for Preventing Post-Traumatic Stress Injuries Among Diverse Public Safety Personnel
|
N/A | |
Not yet recruiting |
NCT05649891 -
Checklists Resuscitation Emergency Department
|
N/A | |
Not yet recruiting |
NCT03696563 -
FreeO2 PreHospital - Automated Oxygen Titration vs Manual Titration According to the BLS-PCS
|
N/A | |
Withdrawn |
NCT03249129 -
Identification of Autoantibodies and Autoantigens in the Cerebrospinal Fluid of Patients With Spinal Cord Trauma
|
||
Completed |
NCT02240732 -
Surgical Tourniquets and Cerebral Emboli
|
N/A | |
Completed |
NCT02227979 -
Effects of PURPLE Cry Intervention
|
N/A | |
Withdrawn |
NCT01169025 -
Fentanyl vs. Low-Dose Ketamine for the Relief of Moderate to Severe Pain in Aeromedical Patients
|
N/A | |
Recruiting |
NCT01812941 -
Evaluation of Mitochondrial Dysfunction in Severe Burn and Trauma Patients
|
N/A | |
Completed |
NCT01475344 -
Fibrinogen Concentrate (FGTW) in Trauma Patients, Presumed to Bleed (FI in TIC)
|
Phase 1/Phase 2 | |
Completed |
NCT03112304 -
Child STEPS for Youth Mental Health in Maine Sustainability
|
N/A | |
Completed |
NCT01201863 -
Neuroendocrine Dysfunction in Traumatic Brain Injury: Effects of Testosterone Therapy
|
Phase 4 | |
Completed |
NCT01210417 -
Trauma Heart to Arm Time
|
N/A |